The company creation fund will deploy capital in ₹30-50 crore cheques over four years to build niche healthcare platforms across oncology, preventive care, and geriatrics, managing partner Pankaj Jethwani told Mint.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.